Bad first
Source Business Line
June 13
Medicis Pharmaceutical Corp said on Friday that it has filed suit against Ranbaxy Laboratories Ltd and Ranbaxy Inc. The suit alleges that Ranbaxy has infringed one or more claims of Medicis’ US patents by submitting to the US Food and Drug Administration an abbreviated new-drug application for a generic version of Solodyn in its 135mg strength. Solodyn is used to treat inflammatory lesions of non-nodular moderate-to-severe acne vulgaris, according to the drug’s Web site. In the suit, Medicis seeks a request for a permanent injunction preventing Ranbaxy from infringing the patent by selling a generic version of the drug
Good
Some Blog site.
Ranbaxy searched for swine flue new fever.